# Airbnb, Inc.: financial statements, quarterly ABNB · Nasdaq · CIK 1559720 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/abnb.md) · [Financials](/companies/abnb/financials.md) · [Filings](/companies/abnb/filings.md) · [Insiders](/companies/abnb/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abnb/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [3,397](/filings/0001559720-24-000032.md) | [2,218 d](/filings/0001559720-26-000004.md) | [2,142](/filings/0001559720-25-000017.md) | [2,748](/filings/0001559720-25-000025.md) | [3,732](/filings/0001559720-25-000030.md) | [2,480 d](/filings/0001559720-26-000004.md) | [2,272](/filings/0001559720-26-000014.md) | [3,096](/filings/0001559720-26-000027.md) | [4,095](/filings/0001559720-25-000030.md) | [2,778 d](/filings/0001559720-26-000004.md) | [2,678](/filings/0001559720-26-000014.md) | [3,608](/filings/0001559720-26-000027.md) | | Cost of revenue | $m | [459](/filings/0001559720-24-000032.md) | [384 d](/filings/0001559720-26-000004.md) | [480](/filings/0001559720-25-000017.md) | [506](/filings/0001559720-25-000025.md) | [465](/filings/0001559720-25-000030.md) | [427 d](/filings/0001559720-26-000004.md) | [506](/filings/0001559720-26-000014.md) | [544](/filings/0001559720-26-000027.md) | [549](/filings/0001559720-25-000030.md) | [487 d](/filings/0001559720-26-000004.md) | [581](/filings/0001559720-26-000014.md) | [633](/filings/0001559720-26-000027.md) | | Research and development | $m | [419](/filings/0001559720-24-000032.md) | [432 d](/filings/0001559720-26-000004.md) | [475](/filings/0001559720-25-000017.md) | [519](/filings/0001559720-25-000025.md) | [524](/filings/0001559720-25-000030.md) | [538 d](/filings/0001559720-26-000004.md) | [568](/filings/0001559720-26-000014.md) | [610](/filings/0001559720-26-000027.md) | [587](/filings/0001559720-25-000030.md) | [589 d](/filings/0001559720-26-000004.md) | [638](/filings/0001559720-26-000014.md) | [672](/filings/0001559720-26-000027.md) | | Operating income | $m | [1,496](/filings/0001559720-24-000032.md) | [(496) d](/filings/0001559720-26-000004.md) | [101](/filings/0001559720-25-000017.md) | [497](/filings/0001559720-25-000025.md) | [1,525](/filings/0001559720-25-000030.md) | [430 d](/filings/0001559720-26-000004.md) | [38.0](/filings/0001559720-26-000014.md) | [612](/filings/0001559720-26-000027.md) | [1,625](/filings/0001559720-25-000030.md) | [269 d](/filings/0001559720-26-000004.md) | [86.0](/filings/0001559720-26-000014.md) | [758](/filings/0001559720-26-000027.md) | | Income tax | $m | [(2,695)](/filings/0001559720-24-000032.md) | [(34.0) d](/filings/0001559720-26-000004.md) | [29.0](/filings/0001559720-25-000017.md) | [126](/filings/0001559720-25-000025.md) | [367](/filings/0001559720-25-000030.md) | [161 d](/filings/0001559720-26-000004.md) | [19.0](/filings/0001559720-26-000014.md) | [137](/filings/0001559720-26-000027.md) | [418](/filings/0001559720-25-000030.md) | [52.0 d](/filings/0001559720-26-000004.md) | [121](/filings/0001559720-26-000014.md) | [81.0](/filings/0001559720-26-000027.md) | | Net income | $m | [4,374](/filings/0001559720-24-000032.md) | [(349) d](/filings/0001559720-26-000004.md) | [264](/filings/0001559720-25-000030.md) | [555](/filings/0001559720-25-000030.md) | [1,368](/filings/0001559720-25-000030.md) | [461 d](/filings/0001559720-26-000004.md) | [154](/filings/0001559720-26-000027.md) | [642](/filings/0001559720-26-000027.md) | [1,374](/filings/0001559720-25-000030.md) | [341 d](/filings/0001559720-26-000004.md) | [160](/filings/0001559720-26-000027.md) | [816](/filings/0001559720-26-000027.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [8.2](/filings/0001559720-23-000020.md) | [6.9](/filings/0001559720-25-000010.md) | [7.8](/filings/0001559720-24-000017.md) | [7.9](/filings/0001559720-24-000024.md) | [7.7](/filings/0001559720-24-000032.md) | [6.9](/filings/0001559720-26-000004.md) | [7.6](/filings/0001559720-25-000017.md) | [7.4](/filings/0001559720-25-000025.md) | [7.5](/filings/0001559720-25-000030.md) | [6.6](/filings/0001559720-26-000027.md) | [7.0](/filings/0001559720-26-000014.md) | [6.8](/filings/0001559720-26-000027.md) | | Current assets | $bn | [17.5](/filings/0001559720-23-000020.md) | [16.5](/filings/0001559720-25-000010.md) | [20.4](/filings/0001559720-24-000017.md) | [22.3](/filings/0001559720-24-000024.md) | [18.3](/filings/0001559720-24-000032.md) | [17.2](/filings/0001559720-26-000004.md) | [21.3](/filings/0001559720-25-000017.md) | [23.2](/filings/0001559720-25-000025.md) | [19.5](/filings/0001559720-25-000030.md) | [18.8](/filings/0001559720-26-000027.md) | [23.6](/filings/0001559720-26-000014.md) | [25.5](/filings/0001559720-26-000027.md) | | Total assets | $bn | [21.4](/filings/0001559720-23-000020.md) | [20.6](/filings/0001559720-25-000010.md) | [24.5](/filings/0001559720-24-000017.md) | [26.3](/filings/0001559720-24-000024.md) | [22.2](/filings/0001559720-24-000032.md) | [21.0](/filings/0001559720-26-000004.md) | [25.1](/filings/0001559720-25-000017.md) | [27.0](/filings/0001559720-25-000025.md) | [23.1](/filings/0001559720-25-000030.md) | [22.2](/filings/0001559720-26-000027.md) | [26.8](/filings/0001559720-26-000014.md) | [28.8](/filings/0001559720-26-000027.md) | | Current liabilities | $bn | [9.8](/filings/0001559720-23-000020.md) | [10.0](/filings/0001559720-25-000010.md) | [14.1](/filings/0001559720-24-000017.md) | [15.8](/filings/0001559720-24-000024.md) | [11.3](/filings/0001559720-24-000032.md) | [10.2](/filings/0001559720-26-000004.md) | [16.7](/filings/0001559720-25-000017.md) | [18.8](/filings/0001559720-25-000025.md) | [14.0](/filings/0001559720-25-000030.md) | [13.6](/filings/0001559720-26-000027.md) | [16.4](/filings/0001559720-26-000014.md) | [18.1](/filings/0001559720-26-000027.md) | | Total liabilities | $bn | [12.3](/filings/0001559720-23-000020.md) | [12.5](/filings/0001559720-25-000010.md) | [16.6](/filings/0001559720-24-000017.md) | [18.3](/filings/0001559720-24-000024.md) | [13.7](/filings/0001559720-24-000032.md) | [12.5](/filings/0001559720-26-000004.md) | [17.1](/filings/0001559720-25-000017.md) | [19.2](/filings/0001559720-25-000025.md) | [14.5](/filings/0001559720-25-000030.md) | [14.0](/filings/0001559720-26-000027.md) | [19.2](/filings/0001559720-26-000014.md) | [21.0](/filings/0001559720-26-000027.md) | | Long-term debt | $bn | [2.0](/filings/0001559720-23-000020.md) | [2.0](/filings/0001559720-25-000010.md) | [2.0](/filings/0001559720-24-000017.md) | [2.0](/filings/0001559720-24-000024.md) | [2.0](/filings/0001559720-24-000032.md) | [2.0](/filings/0001559720-26-000004.md) | [0.0](/filings/0001559720-25-000017.md) | [0.0](/filings/0001559720-25-000025.md) | [0.0](/filings/0001559720-25-000030.md) | [0.0](/filings/0001559720-26-000027.md) | [2.5](/filings/0001559720-26-000014.md) | [2.5](/filings/0001559720-26-000027.md) | | Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001559720-26-000004.md) | [2.0](/filings/0001559720-25-000017.md) | [2.0](/filings/0001559720-25-000025.md) | [2.0](/filings/0001559720-25-000030.md) | [2.0](/filings/0001559720-26-000027.md) | [0.0](/filings/0001559720-26-000014.md) | [0.0](/filings/0001559720-26-000027.md) | | Shareholders' equity | $bn | [9.1](/filings/0001559720-24-000032.md) | [8.2](/filings/0001559720-26-000004.md) | [7.9](/filings/0001559720-25-000030.md) | [8.0](/filings/0001559720-25-000030.md) | [8.5](/filings/0001559720-25-000030.md) | [8.4](/filings/0001559720-26-000027.md) | [7.9](/filings/0001559720-26-000027.md) | [7.8](/filings/0001559720-26-000027.md) | [8.6](/filings/0001559720-25-000030.md) | [8.2](/filings/0001559720-26-000027.md) | [7.6](/filings/0001559720-26-000027.md) | [7.8](/filings/0001559720-26-000027.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [1,325 d](/filings/0001559720-24-000032.md) | [63.0 d](/filings/0001559720-26-000004.md) | [1,923](/filings/0001559720-25-000017.md) | [1,051 d](/filings/0001559720-25-000025.md) | [1,078 d](/filings/0001559720-25-000030.md) | [466 d](/filings/0001559720-26-000004.md) | [1,789](/filings/0001559720-26-000014.md) | [975 d](/filings/0001559720-26-000027.md) | [1,356 d](/filings/0001559720-25-000030.md) | [526 d](/filings/0001559720-26-000004.md) | [1,708](/filings/0001559720-26-000014.md) | [1,270 d](/filings/0001559720-26-000027.md) | | Capital expenditure | $m | [15.0 d](/filings/0001559720-23-000020.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [500 d](/filings/0001559720-24-000032.md) | [752 d](/filings/0001559720-26-000004.md) | [750](/filings/0001559720-25-000017.md) | [749 d](/filings/0001559720-25-000025.md) | [1,093 d](/filings/0001559720-25-000030.md) | [838 d](/filings/0001559720-26-000004.md) | [807](/filings/0001559720-26-000014.md) | [1,010 d](/filings/0001559720-26-000027.md) | [877 d](/filings/0001559720-25-000030.md) | [1,095 d](/filings/0001559720-26-000004.md) | [1,088](/filings/0001559720-26-000014.md) | [1,051 d](/filings/0001559720-26-000027.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [680](/filings/0001559720-23-000020.md) | [670](/filings/0001559720-24-000017.md) | [665](/filings/0001559720-24-000024.md) | [660](/filings/0001559720-24-000032.md) | [654](/filings/0001559720-25-000017.md) | [649](/filings/0001559720-25-000025.md) | [642](/filings/0001559720-25-000030.md) | [632](/filings/0001559720-26-000014.md) | [626](/filings/0001559720-26-000027.md) | [621](/filings/0001559720-25-000030.md) | [608](/filings/0001559720-26-000014.md) | [597](/filings/0001559720-26-000027.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.